Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,725.00
+115.00 (3.19%)
Apr 1, 2025, 3:30 PM KST
Xcell Therapeutics Company Description
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy.
It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells.
Xcell Therapeutics Inc. was incorporated in 2015 and is based in Seoul, South Korea.
Xcell Therapeutics Inc.
| Country | South Korea |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 61 |
Contact Details
Address: Hanwha Biz Metro Bldg. Seoul, 08394 South Korea | |
| Phone | 82 2 863 1331 |
| Website | xcell.co.kr |
Stock Details
| Ticker Symbol | 373110 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7373110006 |
| SIC Code | 2836 |